Gu Sheng called in his stockbroker and asked about the companies listed in Hong Kong.
They could not be too big or too small. Ideally, they would be competing with other companies in certain industries or projects.
"Mr. Gu, in that case, I actually do know one." Tang Liangwei spoke almost as soon as Gu Sheng finished.
"Hong Kong Island Pharmaceutical!"
"Tell me about it!" Gu Sheng immediately became interested.
"Recently, Hong Kong Island Pharmaceutical has been negotiating with Novo Company in Denmark for a license to extract insulin from pigs. They'd been talking for half a month and had broadly agreed on terms when another company suddenly butted in."
"The company that butted in was Kowloon Pharmaceutical, which Hutchison Whampoa just acquired!"
The papers had reported on this several times, so he remembered it clearly.
Gu Sheng grew even more interested. What a coincidence.
He had been sick of Li Ma Sing for ages. If he had not been busy recently, with the Guo Family ahead of him in line, he would have gone looking for trouble with Li Ma Sing long ago.
Gu Sheng thought it over briefly. Li Ma Sing rarely engaged in actual industrial production.
Many people thought Li Ma Sing was an industrialist, but what he actually did most was invest, acquire, break up, and sell.
This Kowloon Pharmaceutical would most likely go through that same process.
"Tell me about these two companies."
Hong Kong Island Pharmaceutical was a long-established pharmaceutical company with quite a few drugs that sold well on Hong Kong Island. However, in recent years, its owner had diverted funds into failed real estate investments, while other drug manufacturers had taken a substantial share of its market, so it was struggling.
Its profit for the first quarter of this year was negative